FFF Enterprises: BioSupply Trends
 
BioSupply Trends - Marketplace News
FFF Enterprises FFF Enterprises | Home FFF Enterprises | Contact Us
Thursday, June 17, 2010
FFF Enterprises | Patient Safety + Product Efficdacy + Fair Pricing
 
In This Issue
  • IVIG Supply Index
  • Albumin Supply Index
  • Open Market Pricing
  • Reimbursement Rates
  • Industry News
  • Subscribe to BST Quarterly
  • Subscribe to IG Living
  • MyFluVaccine Orders
  • Resources
Subscribe to BioSupply Trends eNewsletter
FFF Enterprises
(800) 843-7477
FFF Enterprises | Free Reference Charts for Hyperimmunds, Immune Globulins, Factor and Injectable Influenza
Hyperimmune
Immune Globulin
Factor
Injectable Influenza
Place Your Flu Vaccine Order on MyFluVaccine.com
Place Your Flu Vaccine Order on MyFluVaccine.com
Subscribe to BioSupply Trends Quarterly magazine
BioSupplyTrends Quarterly magazine, your definitive source for the biopharmaceuticals marketplace
Subscribe to IG Living! magazine
IG Living! magazine, the magazine for the immune globulin community
FFF Enterprises | Helping Healthcare Care - place an order

Grifols to Acquire Talecris Biotherapeutics Creating A World Leading Provider Of
Life-Saving Plasma Protein Therapies

The combination of Grifols and Talecris will create a diversified, global provider of life-saving and life enhancing plasma protein therapeutics built on the strong global presence of Grifols and the established position of Talecris in United States and Canada.
Read the full article »


Rotavirus Vaccine Is Now Contraindicated for Infants Diagnosed With Severe Combined Immunodeficiency
In response to reported cases of vaccine-acquired rotavirus infection in infants with severe combined immunodeficiency (SCID) following rotavirus vaccine administration, both Merck & Co. and GlaxoSmithKline Biologicals have revised the prescribing information and patient labeling for their respective rotavirus vaccine products, pentavalent rotavirus vaccine (RV5) and monovalent rotavirus vaccine (RV1), with approval from the Food and Drug Administration (1,2).
Read the full article »

 

 
 
   
 
IVIG Supply Index represents  FFF's aggregate inventory of  all IVIG products for all our  customers who have established  product allocations with us  (not individual or group  allocations).  Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more.  Albumin Supply Index represents FFF's aggregate inventory of Albumin for all our customers who have  established product allocations  with us (not individual or group  allocations). Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more.
 
FFF Enterprises | Open Market Pricing
 
 
Current CMS / IVIG Rates
Product Outpatient Hospital Physician's Office
Carimune NF 60.559 61.724
Flebogamma 5% DIF 72.623 74.020
Gammagard Liquid 75.600 77.054
Gammagard S/D 60.559 61.724
Gamunex 73.830 75.250
Octagam 73.954 75.376
Privigen 68.877 70.202
Rates per gram are effective April 1, 2010 through June 30, 2010
 
 

Industry News

From The CDC
Two Law Firms Challenge Talecris' $4 Billion Merger With Grifols 
more »

From NewsWeek
Six Myths About Childhood Vaccines 

more »

From TVNZ
Flu Vaccine Doses Top One Million 
more »

From The Los Angeles Times
Mexico Cracks Down On Self-Prescribed Antibiotics 

more »

From Health Express UK
World Cup Horns Could Spread Influenza 
more »

 
 
   
   
 
FFF Enterprises | Patient Safety + Product Efficdacy + Fair Pricing
Home | About Us | Contact   ©2010 FFF Enterprises, Inc.